What happened
Walmart shares dropped as much as 8.8 percent on Wednesday 19 August after the retailer reported US comparable sales growth of just 2.6 percent, well short of the 3.7 percent analysts had modelled and the slowest quarterly pace since the fourth quarter of 2020, when growth was 1.9 percent.
The headline numbers were fine. Quarterly revenue came in at 187.9 billion dollars against a FactSet consensus of 186.6 billion, and adjusted earnings were 81 cents per share versus the 74 cents expected. Walmart also raised its full year guidance for both sales and adjusted operating income.
Comparable sales, often shortened to comps, measure growth at stores that have been open for at least a year, stripping out the flattering effect of new store openings. It is the single number that tells you whether an existing customer base is spending more or less, which is why the market weighted it above everything else in the release.
Part of the shortfall was mechanical. Walmart said its pharmacy business created a 0.8 percentage point headwind after federal negotiations on Medicare covered medicines pushed drug prices down. Lower prices on the same volume of prescriptions shows up as weaker sales even when the underlying business is healthy. Strip that out and the picture is less alarming, but investors focused on the raised guidance that still landed below consensus, under a new chief executive in John Furner.
Why it matters
Walmart serves roughly 250 million customers a week and sells everything from groceries to televisions. That makes its results one of the most reliable real time surveys of American consumer behaviour available, arriving weeks before official retail sales data is finalised and covering actual transactions rather than survey responses.
A 2.6 percent comp in an environment where prices are still rising means the volume of goods leaving the shelves is barely growing. Households are buying similar amounts and paying slightly more, rather than trading up. In previous cycles, Walmart has actually gained customers when money gets tight because shoppers move down from more expensive retailers. Weak comps at the discounter is therefore a more worrying signal than weak comps at a luxury brand.
The consumer accounts for close to 70 percent of US economic output, so if American households are pulling back, the growth outlook for the world economy shifts with them. That feeds into corporate profit forecasts, employment plans and, eventually, central bank decisions.
For UK investors, the read across is indirect but real. Most workplace pensions hold global equity trackers, and US shares dominate those indices. A meaningful reassessment of the American consumer would show up in a fund that has nothing obviously to do with a supermarket in Arkansas.
Explained simply
A company can pass its exam and still get marked down, if the examiner cares less about the final score than about whether you are improving. Walmart beat every headline number and was punished for the one line that showed momentum fading.
Share prices are not a verdict on how a company performed. They are a verdict on how it performed relative to what was already assumed. If the market had priced in 3.7 percent comparable sales growth and got 2.6 percent, the shares were carrying an expectation that turned out to be too generous, and the price had to come down to reflect the new one.
Think of comparable sales as the difference between a shop that has grown busier and a chain that has simply opened more shops. Total revenue can rise handsomely just by adding locations. Comps ask the harder question: are the tills at the existing stores ringing more than they did a year ago.
The pharmacy effect is worth understanding because it shows how a good outcome for society can look like a bad outcome on a spreadsheet. If the government negotiates cheaper medicines, patients pay less. Walmart dispenses the same number of prescriptions but records less revenue for doing so. Sales fall, nothing has gone wrong operationally, and the accounting still reads as a miss.
Guidance is the other half of the story. Companies publish forecasts for the quarters ahead, and analysts build their models around them. Walmart raised its guidance, which sounds positive, but raised it by less than the market had already assumed. In a market that trades on the gap between expectation and outcome, that is a downgrade in everything but name.
What it means for you
If you hold a global equity tracker in a stocks and shares ISA or a workplace pension, Walmart is in it. It is a large constituent of the S and P 500, so a fall of this size nudges the index and therefore your fund, though the effect on any single day is small. This is not a reason to trade. Single stock moves inside a diversified index are noise unless they signal something broader.
The broader signal is the one to file away. If US consumer spending is genuinely slowing, that eventually softens corporate earnings across retail, travel and consumer goods. Anyone with a portfolio heavily concentrated in consumer facing shares might reasonably check how exposed they are, rather than assuming a global tracker has spread the risk for them.
UK grocery shoppers can take a different lesson. British grocery inflation slowed to 2.1 percent in the four weeks to 9 August, down from 2.6 percent a month earlier. Supermarket price competition is intensifying on both sides of the Atlantic, which is a genuine opportunity to cut a monthly shop by switching own brand ranges or changing where you buy.
If you are considering individual shares in retail, the Walmart result is a reminder to read past the headline beat. Look at like for like sales, at gross margin, and at whether guidance rose by more or less than the market wanted. Those three lines usually explain the share price reaction better than earnings per share does.
The bigger picture
The last time Walmart posted comparable sales growth this weak was the fourth quarter of 2020, a period distorted by pandemic restrictions. Reaching that level in an ordinary trading quarter is a different and more meaningful thing, because there is no lockdown to blame.
The result landed on a day when bond yields were rising and expectations for monetary policy were tightening, a combination that leaves little tolerance for disappointment. Retailers reporting into that backdrop are being judged harshly, as Target and Estee Lauder demonstrated in the opposite direction when their beats were rewarded with sharp gains.
Watch the next two quarters for whether 2.6 percent was a floor or a trend. Watch also whether the pharmacy drag persists, since Medicare drug price negotiation is a structural policy change rather than a one off. And watch how John Furner frames the strategy in his first full year, because a new chief executive facing slowing comps usually has to choose between defending margins and defending market share.
